Similarly, CVII is a commonly used route of administration for controlling PN-associated hyperglycemia; the insulin can be rapidly absorbed and can rapidly correct hyperglycemia, making CVII the preferred insulin infusion method for critically ill or hemodynamically unstable patients (52). The gene discussed is INS; the disease is Hyperglycemia.